Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-21
1997-12-16
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142315, 514252, 514278, 514397, 514409, 549332, A61K 31335, C07D40708
Patent
active
056985860
ABSTRACT:
O-substituted fumagillol derivatives and its salts have an angiogenesis inhibiting activity and are useful for prophylaxis and treatment of diseases induced by abnormally stimulated neovascularization.
REFERENCES:
patent: 4954496 (1990-09-01), Oku et al.
patent: 5135919 (1992-08-01), Folkman et al.
Chemical Abstracts, vol. 70, No. 9, 3rd Mar. 1969, p. 206, Abstract No. 36365g, Columbus, Ohio, US; M.M. Maevskii, et al.
Chemical Abstracts, vol. 106, No. 21, 25th May 1987, p. 706, Abstract No. 176153y, Columbus, Ohio, US; & JP-A-62 00 476 (Fujisawa Pharmaceutical Co., Ltd.).
Derwent Printout from Dialog of the abstract corresponding to Japanese Kokai Tokkyo Koho No. 58-131978 (1983).
Derwent Printout from Dialog of the abstract corresponding to Japanese Kokai Tokkyo Koho No. 63-119500 (1988).
S. Taylor, et al., Nature, 297:307 (1982).
J. Folkman, et al., Science, 221:719 (1983).
D. Tarbell, et al., J. Am. Chem. Soc. 83:3096 (1961).
O. Mitunobu, Synthesis, (1981), 1, pp. 1-28.
I. Sutherland (Ed.), "Comprehensive Organic Chemistry", vol. 2, pp. 4-11, Pergamon Press (1979).
Gimbrone, et al., J. National Cancer Institute, 52:413-419 (1974).
J. Ross, et al., J. Am. Chem. Soc., 78:4675 (1956).
Falk, et al., J. Immunol. Meth., 33:239-247 (1980).
Folkman, et al., Science, 230:1375 (1985).
Chemical Patent Index, Basic Abstracts Journal Section B, Week 8706, Abstract No. 87-040948/06, Abstract of JP-A-476/1987.
J. DiPaolo, et al., Antibiotics Annual, 1958-1959, pp. 541-546.
G. Ruecker, et al. Chemical Abstracts, 77:29f (1972).
The Merck Index, 11th Ed., (1989) pp. 670-671; Compound No. 4199-Fumagillin .
Folkman Moses Judah
Fujita Takeshi
Ingber Donald
Kanamaru Tsuneo
Kishimoto Shoji
Conlin David G.
Datlow Philip I.
Eisenstein Ronald I.
Resnick David S.
Takeda Chemical Industries, Ltd
LandOfFree
Angiogenesis inhibitory agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiogenesis inhibitory agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibitory agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206776